Clinical Trials Logo

Clinical Trial Summary

Get a better understanding of the pathophysiological processes of acute respiratory failure following cardiopulmonary bypass to initiate timely therapies targeted on a cell line.

Demonstrate that there is a relationship between increased transpulmonary gradients of inflammation biomarkers (sRAGE, sICAM-1, SPB, PAI-1, ROS) and pulmonary vascular resistance on the one hand and alveolo-capillary gas exchange on the other hand after cardiac surgery under cardiopulmonary bypass.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Acute Lung Injury
  • Acute Respiratory Distress Syndrome After Cardiac Surgery Under Cardiopulmonary Bypass
  • Respiratory Distress Syndrome, Adult
  • Respiratory Distress Syndrome, Newborn

NCT number NCT01723930
Study type Observational
Source University Hospital, Strasbourg, France
Contact Julien POTTECHER, MD
Phone 03 88 12 70 95
Email julien.pottecher@chru-strasbourg.fr
Status Not yet recruiting
Phase N/A